Skip to main content
. Author manuscript; available in PMC: 2022 Feb 23.
Published in final edited form as: Biologicals. 2018 Nov 18;57:9–20. doi: 10.1016/j.biologicals.2018.11.001

Table 1.

Sera for MMACA assay development and characterization.

Reagent ID Formulation Dilution Factor Expected IgG concentration (IU or AU/mL)
Act Fha Fim2/3 Prn Pt

2012812612a Neat 129.92 113.58 1153.47 1299.40 171.28
MCR0001 2 64.96 56.79 576.74 649.70 85.64
MCR0002 4 32.48 28.40 288.37 324.85 42.82
MCR0003 16 8.12 7.10 72.09 81.21 10.71
MCR0004 30 4.33 3.79 38.45 43.31 5.71
MCR0005 120 1.08 0.95 9.61 10.83 1.43
MCR0006 500 0.26 0.23 2.31 2.60 0.34
MCR0007 2000 0.06 0.06 0.58 0.65 0.09

2012789123a Neat 264.62 1015.55 320.60 1771.89 45.86
MCR0008 2 132.31 507.78 160.30 885.95 22.93
MCR0009 4 66.16 253.89 80.15 442.97 11.47
MCR0010 16 16.54 63.47 20.04 110.74 2.87
MCR0011 30 8.82 33.85 10.69 59.06 1.53
MCR0012 120 2.21 8.46 2.67 14.77 0.38
MCR0013 500 0.53 2.03 0.64 3.54 0.09
MCR0014 2000 0.13 0.51 0.16 0.89 0.02

WHO06/142a Neat 64.65 107.11 38.51 29.50 82.88
MCR0015 2 32.33 53.56 19.26 14.75 41.44
MCR0016 4 16.16 26.78 9.63 7.38 20.72
MCR0017 6 10.78 17.85 6.42 4.92 13.81
MCR0018 12 5.39 8.93 3.21 2.46 6.91
MCR0019 50 1.29 2.14 0.77 0.59 1.66
MCR0020 200 0.32 0.54 0.19 0.15 0.41
MCR0021 750 0.09 0.14 0.05 0.04 0.11

Act – Adenylate cyclase; Fha – filamentous hemagglutinin; Fim2/3 - Fimbria; Prn – Pertactin; Pt – Pertussis toxin antigens.

a

Human sera spiked into human serum depleted of total IgG, IgA and IgM (MCR0028) to formulate a serum panel (MCR0001 – MCR0021) for MMACA assay development and characterization.